In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Patients with an implantable converter-defibrillator (ICD) that uses fracture-prone Fidelis leads have similar survival rates as ICD patients with another type of lead,…
NEW YORK (Reuters Health) – Patients with previously untreated multiple myeloma do better when they are given an autologous stem-cell transplant followed by an allogeneic transplant from a…
NEW YORK (Reuters Health) – Bronchodilation is well maintained in patients with chronic obstructive pulmonary disease (COPD) using the long-acting beta-2-agonist indacaterol during 1 year of treatment, investigators…
NEW YORK (Reuters Health) – Patients with arthritis acknowledge having thoughts of suicide twice as often as people without arthritis, researchers report. “Suicidal ideation is prevalent among adults…
NEW YORK (Reuters Health) – Patients with depression or diabetes have an increased risk of MI, but the risk is even higher in patients with both conditions, according…
NEW YORK (Reuters Health) – Among older women with breast cancer, specific comorbid conditions are independently associated with decreased survival, according to a report in the Journal of…
NEW YORK (Reuters Health) – African Americans are less likely to develop atrial fibrillation after isolated coronary artery bypass graft (CABG) surgery than European Americans, a new study…
NEW YORK (Reuters Health) – When performed at centers of excellence, robotic partial nephrectomy (RPN) has “an acceptably low” complication rate that mirrors that of open partial nephrectomy…
NEW YORK (Reuters Health) – Metformin beginning at the age of 8 years in girls at risk of polycystic ovary syndrome (PCOS) is more effective than a later…
NEW YORK (Reuters Health) – After six monthly intraocular injections of ranibizumab (Lucentis; Genentech) for macular edema, the benefits are maintained for another 6 months when ranibizumab is…
